Literature DB >> 34733683

Erratum to study on the mechanism of the Modified Ginseng-Schisandra Decoction (MGSD) in the treatment of recurrent respiratory tract infection (RRTI) based on network pharmacology.

.   

Abstract

[This corrects the article DOI: 10.21037/tp-21-240.]. 2021 Translational Pediatrics. All rights reserved.

Entities:  

Year:  2021        PMID: 34733683      PMCID: PMC8506062          DOI: 10.21037/tp-21-416

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN: 2224-4336


The article entitled “Study on the mechanism of the Modified Ginseng-Schisandra Decoction (MGSD) in the treatment of recurrent respiratory tract infection (RRTI) based on network pharmacology” (1) that appeared on Page: 1701-1711, Vol 10, No. 6 (June 2021) unfortunately contained a mistake in the section of Funding. The corrected information is presented as below. Funding: Shanghai Municipality’s three-year action plan for further accelerating the development of Chinese medicine (2018-2020) [ZY (2018-2020)-FWTX-4023, ZYPY (2018-2020)-043]; Shanghai Municipal Health Commission’s Maternal and Child Health TCM Special Construction Project (FYJKZY-EB-2). Click here to view the updated version of the article.
  1 in total

1.  Study on the mechanism of the Modified Ginseng-Schisandra Decoction (MGSD) in the treatment of recurrent respiratory tract infection (RRTI) based on network pharmacology.

Authors:  Qing-Ke Cui; Hua Li; Zhan Li; Jie Li; Liqi Song
Journal:  Transl Pediatr       Date:  2021-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.